Ruxolitinib Phosphate Clinical Trials
3 recruitingDrug
Phase 21Phase 31Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 1
Ruxolitinib in Combination With CHOP Chemotherapy for the Treatment of Untreated Nodal T-Follicular Helper Cell Lymphomas
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedMature T-Cell and NK-Cell Non-Hodgkin LymphomaFollicular Helper T-Cell Lymphoma+3 more
City of Hope Medical Center20 enrolled1 locationNCT07278856
Recruiting
Phase 3
A Clinical Trial of Flonoltinib Maleate for Intermediate or High-Risk Myelofibrosis
MF
Chengdu Zenitar Biomedical Technology Co., Ltd105 enrolled2 locationsNCT07317700
Recruiting
Phase 2
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome
City of Hope Medical Center40 enrolled1 locationNCT06128070